Ovid Therapeutics Inc.

OVID·NASDAQ·$2.45Share Price as of 11/2·$323MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/26 10-QQ1 ended 03/31/2605/12/26 10-KFY 202503/18/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/13/25

Disclosures

8-KCurrent report08/13/26 8-KCurrent report07/08/26 8-KCurrent report06/11/26 8-KCurrent report06/03/26 8-KCurrent report05/12/26

Prospectuses and Registrations

424B3Prospectus04/27/26 S-3Shelf registration04/21/26 S-8Registration of securities for employees03/18/26 424B3Prospectus12/22/25 S-3Shelf registration12/15/25

Proxies

DEF 14ADefinitive proxy04/27/26 DEFA14AAdditional proxy materials04/27/26 DEF 14ADefinitive proxy11/07/25 PRE 14APreliminary proxy10/28/25 PREM14APreliminary proxy (merger)10/27/25

Ownership

144Proposed sale of securities08/24/26 144Proposed sale of securities08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26

Other

ARSAnnual report to shareholders04/27/26 EFFECTRequest for effectiveness04/24/26 CORRESPCorrespondence with the SEC04/23/26 UPLOADLetter from the SEC04/23/26 EFFECTRequest for effectiveness12/22/25